title: Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell.
abstract: Androgen deprivation causes a reduction of blood flow in the prostate gland that precedes temporally apoptosis of the epithelium. The acute response of prostate endothelial cells to androgen deprivation suggested they represent a primary target for androgen. However, rat prostate endothelial cells were reported not to express androgen receptor (AR), and the role of the androgen axis in human prostate endothelial cell (HPEC) homeostasis was poorly characterized. In this study AR expression was detected in HPEC in vivo in clinical specimens of benign prostate and prostate cancer, and AR function as a transcription factor was demonstrated in HPEC in primary xenografts of human benign prostate tissue transplanted into severe combined immunodeficient mice by iv administration of adenoviral mouse mammary tumor virus-driven luciferase expression vector. AR expression and functionality were maintained in vitro in primary cultures of HPEC that coexpressed CD31, CD34, von Willebrand factor, intercellular adhesion molecule, vascular endothelial growth factor receptor 1, and vascular endothelial growth factor receptor 2 but did not express prostate-specific antigen. AR expression in primary cultures of HPEC isolated from surgical specimens of benign prostate was validated using RT-PCR, cDNA sequencing, immunocytochemistry, and Western blot analyses. Scatchard analyses demonstrated a single ligand-binding site for R1881 in primary cultures of HPEC, with dissociation constant of 0.25 nm, and AR-mediated transcriptional activity was demonstrated using adenoviral mouse mammary tumor virus-driven luciferase reporters. Dihydrotestosterone increased proliferation in primary cultures of HPEC in a dose-dependent manner without modulating endothelial tube formation in Matrigel (BD Biosciences, Bedford, MA). Therefore, HPECs express functional AR, and androgen plays a direct role in modulating HPEC biology.
authors.affiliation: Department of Urologic Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Godoy
authors.forename: Anica
authors.initials: A
authors.lastname: Watts
authors.forename: Paula
authors.initials: P
authors.lastname: Sotomayor
authors.forename: Viviana P
authors.initials: VP
authors.lastname: Montecinos
authors.forename: Wendy J
authors.initials: WJ
authors.lastname: Huss
authors.forename: Sergio A
authors.initials: SA
authors.lastname: Onate
authors.forename: Gary J
authors.initials: GJ
authors.lastname: Smith
mesh_terms: D000818:Animals; D042783:Endothelial Cells / Q000502:physiology* / Q000637:transplantation; D004730:Endothelium, Vascular / Q000502:physiology; D006706:Homeostasis; D006801:Humans; D008297:Male; D051379:Mice; D016513:Mice, SCID; D011467:Prostate / Q000502:physiology* / Q000637:transplantation; D051381:Rats; D011944:Receptors, Androgen / Q000235:genetics / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014183:Transplantation, Heterologous; D014471:Umbilical Veins / Q000502:physiology
chemical_list: D011944:Receptors, Androgen